Keywords
Estradiol valerate
Labor induction
Submitted : 2022-01-19
Accepted : 2022-02-03
Published : 2022-02-18
Abstract
Background: Cervical ripening is an important factor in predicting successful labor induction. In an unfavorable cervix, ripening should be done before induction. In this study, the effect of misoprostol and that of misoprostol plus estradiol on cervical ripening were compared. Methods: This randomized, double-blinded study included a total of 190 pregnant women who were identified for pregnancy termination due to maternal or fetal cause at 37 weeks with Bishop score of less than 4. The patients were assessed between April 2015 to April 2016 in two university hospitals at northeast Iran (Omol-Banin Hospital and Emam Reza Hospital, Mashhad). The patients who met the inclusion criteria were randomly assigned to two groups: the intervention group (Group A), who received 25 micrograms of vaginal misoprostol plus 50 micrograms of estradiol, and the control group (Group B), who received 25 micrograms of vaginal misoprostol only. Misoprostol was administered at 4-hour intervals until cervical ripening (Bishop score ? 8) or upon initiation of active phase in both the groups. The maximum dosage of misoprostol was three doses, whereas estradiol was administered only once. Results: In this study, the main causes of pregnancy termination were ROM and post-term. There was no significant statistical difference in the Bishop score between the two groups (P = 0.13). In addition, no significant difference was observed in the duration of time for cervical ripening (Bishop ? 8) between the two groups (P = 0.7). The duration between drug administration to the initiation of active phase and also from active phase to delivery showed no significant differences between the two groups (P = 0.49 and 0.24, respectively). There was also no significant difference in the delivery route (operative vaginal delivery or Cesarean section) (P = 0.2 and P = 0.91, respectively). Conclusion: From this study, the use of misoprostol plus estradiol did not improve cervical ripening or decrease the induction time. Further studies are recommended to investigate complementary results.
References
James DK, Steer PJ, Weiner CP, et al., 2014, High Risk Pregnancy: Management Options. Elsevier Saunders, 1145-1148.
Wing DA, Tran S, Paul RH, 2002, Factors Affecting the Likelihood of Successful Induction After Intravaginal Misoprostol Application for Cervical Ripening and Labor Induction. Am J Obstet Gynecol, 186(6): 1237-1240; discussion 1240-1243.
Andersson S, Minjarez D, Yost NP, et al., 2008, Estrogen and Progesterone Metabolism in the Cervix during Pregnancy and Parturition, 93(6): 2366-2374.
Laughon SK, Zhang J, Troendle J, 2011, Using a Simplified Bishop Score to Predict Vaginal Delivery. Obstetrics & Gynecology, 117(4): 805-811.
Cunningham FG, Leveno KJ, Bloom SL, et al., 2018, Obstetrics, 25th Edition, MC Graw Hill, New York, 523-532.
Alfirevic Z, Aflaifel N, Weeks A, 2014, Oral Misoprostol for Induction of Labour. Cochrane Database Syst Rev, 2014(6): CD001338.
Mazhar SB, Imran R, Alam K, 2003, Trial of Extra Amniotic Saline Infusion with Oxytocin Versus Prostaglandin E2 Pessary for Induction of Labor. J Coll Physicians Surg Pak, 13: 317-320.
Nizard J, Cromi A, Molendijk H, et al., 2005, Neonatal Outcome Following Prolonged Umbilical Cord Prolapse in Preterm Premature Rupture of Membranes. BJOG, 112(6): 833-836.
Luque EH, Muñoz de Toro MM, Ramos JG, et al., 1998, Role of Relaxin and Estrogen in the Control of Eosinophilic Invasion and Collagen Remodeling in Rat Cervical Tissue at Term. Biol Reprod, 59(4): 795-800.
Konopka CK, Morais EN, Naidon D, et al., 2013, Maternal Serum Progesterone, Estradiol and Estriol Levels in Successful Dinoprostone-Induced Labor. Braz J Med Biol Res, 46(1): 91-97.
Gordon AJ, Calder AA, 1977, Oestradiol Applied Locally to Ripen the Unfavourable Cervix. Lancet, 2(8052-8053): 1319-1321.
Magann EF, Perry KG Jr, Dockery JR Jr, et al., 1995, Cervical Ripening Before Medical Induction of Labor: A Comparison of Prostaglandin E2, Estradiol, and Oxytocin. Am J Obstet Gynecol, 172(6): 1702-1706; discussion 1704-1708.
Dasgupta E, Singh G, 2012, Vaginal Misoprostol Vs Vaginal Misoprostol with Estradiol for Labor Induction: A Prospective Double Blind Study. J Obstet Gynaecol India, 62(1): 47-51. DOI: 10.1007/s13224-012-0156-6
Fritz MA, Speroff L, 2011, Clinical Gynecologic Endocrinology and Infertility, 8th Edition, Lippincot Williams and Wilkins, Philadelphia, 322-323.
Roztocil A, Pilka A, Jelinek J, et al., 1998, A Comparison of Three Preinduction Cervical Priming Methods: Prostaglandins E2 Gel, Dilapan S Rods and Estradiol Gel. Ceska Gynecol, 63(1): 3–9.
Quinn MA, Murphy AJ, Kuhn RJP, et al., 2005, A Double Blind Trial of Extra-Amniotic Oestriol and PGF2a Gels in Cervical Ripening. BJOG, 88(6): 644-649.
Hall R, Gardea M, Harlass F, 2002, Oral Versus Vaginal Misoprostol for Labor Induction. Obstet Gynecol, 99(6): 1044-1048.
Morris M, Bolnga JW, Verave O, et al., 2017, Safety and Effectiveness of Oral Misoprostol for Induction of Labour in a Resource-Limited Setting: A Dose Escalation Study. BMC Pregnancy and Childbirth, 17(1): 298.
Yue H, Ye NH, Li CJ, et al., 2010, Clinical Observation on the Efficacy of Intrauterine Device Removal in Postmenopausal Women by Methyl Carboprost. Chinese Journal of Misdiagnosis, 10: 4381.
Gkrozou F, Koliopoulos G, Vrekoussis T, et al., 2011, A Systematic Review and Meta-Analysis of Randomized Studies Comparing Misoprostol Versus Placebo for Cervical Ripening Prior to Hysteroscopy. Eur J Obstet Gynecol Reprod Biol, 158(1): 17-23.
Selk A, Kroft J, 2011, Misoprostol in Operative Hysteroscopy: A Systematic Review and Meta-Analysis. Obstet Gynecol, 118(4): 941-949.
Raksha M, Rao AA, Kamath A, et al., 2013, Induction of Labor in Unfavourable Cervix: Vaginal Misoprostol Versus Vaginal Misoprostol with Estradiol. Int J Pharm Biomed Res, 4(4): 202-205.
Larmon JE, Magann EF, Dickerson GA, et al., 2002, Outpatient Cervical Ripening with Prostaglandin E2 and Estradiol. J Matern Fetal Neonatal Med, 11(2): 113-117.